Pharmaceutical compositions comprising antihypertensive substances combined with a hypolipemiant agent for treating systemic hypertension and dyslipidemias.
MXPA05014086A
Pharmaceutical compositions containing combined platelet aggregation inhibiting substances for use in the treatment and prevention of ischemic vascular events.
MXPA05014089A
Pharmaceutical compositions containing substances that inhibit the reuptake of noradrenaline, dopamine and serotonin, which are combined with an amino acid for the treatment of obesity and overweight.
MXPA05014091A
Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause.
MXPA05014090A
Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight.
MXPA05014087A
Pharmaceutical compositions containing calcium antagonist substances combined with platelet aggregation inhibiting agents for use in systemic arterial hypertension and for the prevention of ischemic vascular events.
MXPA05014088A
Pharmaceutical compositions containing antihypertensive substances combined with platelet aggregation inhibiting substances for use in the treatment and prevention of ischemic vascular events.
MXPA05014092A
Pharmaceutical compositions containing derivative substances of thiazolidinediones combined with a biguanide for use in type 2 diabetes mellitus.
MXPA05013696A
Pharmaceutical compositions comprising a combination of angiotensin ii antagonist substances, and a hypolipemiant agent for treating systematic hypertension with dyslipidemia.
MXPA05013654A
Pharmaceutical compositions comprising lipstatin hydrogenated derivatives and selective inhibitors in the serotonin (5-ht) capture for treating obesity and tobacco smoking.
MXPA05013220A
Pharmaceutical compositions comprising combined antidiabetic substances for treating diabetes mellitus type 2.
